# Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions

> **NCT00884442** · PHASE1 · COMPLETED · sponsor: **SocraTec R&D GmbH** · enrollment: 28 (actual)

## Conditions studied

- Bioavailability, Therapeutical Indication Not Studied

## Interventions

- **DRUG:** Nifedipine (Gen-nifedipine extended release, previously referred to as Gen-Nifedipine XL)
- **DRUG:** Nifedipine (Bayer Healthcare AG manufactured as Adalat® XL®, Adalat® LA, Adalat® Crono, Adalat® OROS)

## Key facts

- **NCT ID:** NCT00884442
- **Lead sponsor:** SocraTec R&D GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2009-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00884442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00884442, "Nifedipine Bioavailability Study With Oral Single Doses Under Fasting and Fed Conditions". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00884442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*